NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

AIDS Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Vaccine Development



"Design of Attenuated Recombinant Salmonella typhimurium Strains Producing HIV and HBV Antigens."



August 23rd, 1999

According to an abstract submitted by the authors to the 10th Symposium on HIV Infection, held June 17-19, 1999, in Toulon, France, "The aim of this study is construction of HIV and HBV vaccines using an attenuated Salmonella as vaccine carriers. The recombinant strains producing TBI (artificial protein which contains T- and B-cell epitopes of HIV), HBcAg, and chimeric core protein exposing on their surface the major immunogenic epitope of HBsAg (HBcAg-H-Bs) were constructed on the base of attenuated S. typhimurium strains. It was demonstrated that obtained Salmonella strains produced proteins which are able to self-assemble into the virus-like particles and display...


Source: AIDS Weekly (1999-08-23)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login